Letters to the Editor
Clarifications on Patients Presenting with Jaundice
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2005 Feb 1;71(3):425-426.
to the editor: I read with great interest the review on “Jaundice in the Adult Patient,”1 by Drs. Roche and Kobos in the January 15, 2004, issue of American Family Physician. I think it is an easy to read and well-organized review; however, it contained certain inaccuracies.
The authors state, “Abdominal pain is the most common presenting symptom in patients with pancreatic or biliary tract cancers.”1 In fact, the most common presentation in patients with pancreatic cancer is jaundice (72 percent of patients versus 36 percent of patients with abdominal pain).2 Furthermore, by the time patients present with abdominal pain, they usually have unresectable tumors.3
In the paragraph discussing posthepatic causes of jaundice, the authors estimate that cholangiocarcinoma “is associated with an approximately 50 percent survival rate.”1 This survival rate is too optimistic, because it is well known that cholangiocarcinoma is usually associated with a very poor prognosis. Cholangiocarcinoma is almost always a fatal malignancy, primarily because it usually is diagnosed at a late stage (similar to pancreatic cancer).4
Finally, in their discussion of serum testing, the authors report that hemolysis “is indicated by the presence of fractured red blood cells (schistocytes) and increased reticulocytes on the smear.” I would like to clarify that schistocytes are seen only in microangiopathic hemolysis (disseminated intravascular coagulopathy, thrombocytopenic purpura), which is a subset of the hemolytic anemia family, but not present in all forms of hemolytic anemia, and with intravascular prostheses.
1. Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician. 2004;69:299-304.
2. Yazbeck MF. Update on pancreatic cancer. The resident reporter of the American Gastroenterology Association, vol 7. November 2002.
3. Feldman M, Friedman LS, Sleisenger MH. Sleisenger & Fordtran's Gastrointestinal and liver disease: pathophysiology, diagnosis, management. 7th ed. Philadelphia: Saunders, 2002.
4. Sohn TA, Lillemoe KD, Cameron JL, Huang JJ, Pitt HA, Yeo CJ. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s. J Am Coll Surg. 1999;188:658-66.
editor's note: This letter was sent to the authors of “Jaundice in the Adult Patient,” who declined to reply.
Send letters to Kenneth W. Lin, MD, MPH, Associate Deputy Editor for AFP Online, e-mail: firstname.lastname@example.org, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680.
Please include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the American Academy of Family Physicians permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
Copyright © 2005 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions